WEBINAR | Patient-Specific Dosing vs. Protocolized Care: Clinical Superiority for Glycemic Management in the Age of CMS Reporting

Rona Schechter, MPH, RDN, CDCES, System Director, Diabetes Service Line Sharp HealthCare; Gregory Deines, DO, Division Chief of Diabetes and Endocrinology, Corewell Health; and Paul Chidester, MD, FACP, Medical Director for EndoTool, Glooko. As CMS mandates Hospital Harm reporting in 2026, standard protocols for glycemic control have become a visible system-level risk. Join Paul Chidester, MD, Medical Director of EndoTool, along with clinical leaders from Sharp HealthCare and Corewell Health, to discover why EHR-native tools and other insulin dosing protocols often fail the most vulnerable patients. Learn how patient-specific predictive modeling, accounting for real-time renal function and insulin-on-board, is the essential strategy for eliminating glycemic harm and securing your hospital’s standing in the new era of quality reporting.